| Aug 25 2014 |
Northern District of Illinois Court Answers the Question: What KIND of Juice Did They Say It Was? |
Proskauer Rose LLP |
| Aug 25 2014 |
FDA Notifies Congress of Framework for Long-Awaited Guidance on Laboratory Developed Tests and Issues Final Guidance on Companion Diagnostics |
Mintz |
| Aug 25 2014 |
FDA Issues Draft Guidance on De Novo Process |
Barnes & Thornburg LLP |
| Aug 25 2014 |
Medical Device Update: FDA Issues Draft Guidance on Streamlined De Novo Classification Process |
Morgan, Lewis & Bockius LLP |
| Aug 25 2014 |
Prescription Drugs: Refocusing the False Claims Act Microscope on the Rest of the Transaction |
Mintz |
| Aug 25 2014 |
Physicians Write Letter to FDA Regarding Biosimilar Naming Concerns |
McDermott Will & Emery |
| Aug 25 2014 |
FDA’s Announced Framework for Regulating Laboratory Developed Tests (LDTs) Leaves Open Many Questions |
Covington & Burling LLP |
| Aug 22 2014 |
Office of Inspector General (OIG) Finds Risk of Abuse in Specialty Pharmacy’s Per-Fill Fee Proposal |
Mintz |
| Aug 22 2014 |
Pennsylvania Federal Judge Upholds Poaching Claims in Pharmaceutical Data Antitrust Case |
McDermott Will & Emery |
| Aug 21 2014 |
Liquor License Lottery Drawing Application Period Opens for Florida |
Lowndes, Drosdick, Doster, Kantor & Reed, P.A. |
| Aug 21 2014 |
Minnesota Drug Testing Law Does Not Apply to Employees Working Outside Minnesota |
Jackson Lewis P.C. |
| Aug 21 2014 |
FDA Says “Fuhgeddaboudit” To Its Own Proposed Pre-Decisional IDE Process |
Barnes & Thornburg LLP |
| Aug 21 2014 |
Second Circuit Clarifies the Use of Legal Presumptions of Consumer Confusion and Injury in Certain Lanham Act Cases |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 19 2014 |
FDA Issues Final Guidance on "In Vitro Companion Diagnostic Devices" |
Covington & Burling LLP |
| Aug 19 2014 |
FDA Issues Guidance for Drug & Device Companies’ Social Media Interactions |
McBrayer, McGinnis, Leslie and Kirkland, PLLC |
| Aug 18 2014 |
The Food Fight Continues: Vermont AG Seeks to Dismiss Lawsuit Against GMO Labeling Law |
Mintz |
| Aug 18 2014 |
Office of Inspector General (OIG) Issues Unfavorable Advisory Opinion to Specialty Pharmacy For Support Service Payments |
Giordano, Halleran & Ciesla, P.C. |
| Aug 18 2014 |
CMS Re-Opens Open Payments System |
Mintz |
| Aug 17 2014 |
CMS Finalizes Program Changes for Medicare Advantage and Prescription Drug Benefit Programs - Alert! |
Jackson Lewis P.C. |
| Aug 15 2014 |
Circuits Split Over Legality of IRS Rule Mandating Tax Credits for Individuals Covered Through Federal Exchanges under the Affordable Care Act |
Greenberg Traurig, LLP |
| Aug 15 2014 |
FDA Releases Guidelines for 12- Year Period of Reference Product Exclusivity for Section 351(a) Biologics |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
| Aug 13 2014 |
Biotechnology/Pharma Patents: Immune to Post Grant Challenges? |
Armstrong Teasdale |
| Aug 13 2014 |
Office of Inspector General (OIG) Approves Manufacturer’s Direct-to-Patient Discount Sales Program |
Mintz |
| Aug 12 2014 |
Pharmatech Solutions, Inc. v. LifeScan Scotland Ltd.: Final Written Decision IPR2013-00247 |
Faegre Drinker |
| Aug 12 2014 |
Energy & Environmental Law Update - August 11, 2014 |
Mintz |
| Aug 12 2014 |
Patent Practitioners: Inventions and the Ecosystem of Ideas |
Womble Bond Dickinson (US) LLP |
| Aug 12 2014 |
The Centers for Medicare & Medicaid Services (CMS) Temporarily Closes the Open Payments System |
Mintz |
| Aug 12 2014 |
Health Care Law Update - August 11, 2014 |
Mintz |
| Aug 12 2014 |
Sham Hatch-Waxman Infringement Suits And FDA Citizen Petitions; A Potential For New Liability For Innovators? |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 11 2014 |
FDA Notifies Congress that It Intends to Regulate Laboratory Developed Tests |
Barnes & Thornburg LLP |
| Aug 11 2014 |
MHRA creates new expert advisory group on medical devices |
Covington & Burling LLP |
| Aug 8 2014 |
FDA Announces Intent to Issue Draft Guidance Documents Describing Regulatory Framework for Laboratory Developed Tests |
Covington & Burling LLP |
| Aug 8 2014 |
Medical Devices: Parallel Claims Against Device Manufacturers post-Riegel? |
Sills Cummis & Gross P.C. |
| Aug 8 2014 |
NLRB’s Sobering Decision Permits Union Representation Before Employee Drug Test |
Jackson Lewis P.C. |
| Aug 7 2014 |
FDA Releases Final Guidance on Expedited Center for Devices and Radiological Health (CDRH) Appeals |
Barnes & Thornburg LLP |
